Zoetis Inc. (NYSE:ZTS) is one of the Good Stocks to Buy According to Analysts. On December 2, Zoetis Inc. (NYSE:ZTS) held its ...

In a wide-ranging discussion on the future of genomics and cancer diagnostics in India, senior leaders from Strand Life ...

In this exclusive interview with Fortune India , Nandita Sinha, CEO – Myntra, breaks down how social media, content-led ...

Bulgaria-fouded software developer Lab Thread said on Monday that it launched the Beta version of its genetic and research laboratories management platform, six months after securing an investment of ...

Have you ever bitten into a supermarket tomato and wondered where all the flavor went? You're not imagining things. That ...

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Daniel George came from detecting gravitational waves from black holes as part of a Nobel-prize winning team to building TwinMind, one of Silicon Valley’s most promising AI companies.

Martin Babler, CEO of South San Francisco drug-development company Alumis, said skittishness among investors concerned about ...

Cardio Diagnostics announced that CMS has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD™ and PrecisionCHD™ tests.

Regeneron Pharmaceuticals, Inc. REGN announced a collaboration agreement with private company Tessera Therapeutics, Inc. for ...